Acetate, TFA or free base: why the salt form on a peptide label matters

The question behind "acetate" on a label

Two quotes for the same named peptide may say "TFA salt," "acetate salt," "HCl salt" or nothing at all. Buyers ask whether the difference matters. It does, for both laboratory interpretation and regulatory identity, and the reasons can be stated from primary sources.

This guide concerns laboratory documentation. It does not compare effects in people or suggest any use.

Where TFA comes from and why assays care

Cornish and colleagues wrote in 1999 that peptides purified by HPLC are often in the form of a TFA salt because trifluoroacetic acid is used as a solvent in reversed-phase HPLC separation. In their cell-culture experiments, TFA at 10^-8 to 10^-7 M reduced cell numbers and thymidine incorporation in fetal rat osteoblast cultures after 24 hours, with similar effects in articular chondrocytes and neonatal mouse calvariae. [1]

When the authors compared TFA and hydrochloride salts of amylin, amylin-(1-8) and calcitonin, proliferation was consistently lower with the TFA salts, which could hide a proliferative effect or wrongly suggest an antiproliferative one. They recommended converting such peptides to a hydrochloride or biologically equivalent salt before assessing biological effects. [1] That is one study in specific cell systems; record it as a reason to document the salt, not as a general toxicity finding.

Counter-ions also change the material

A 2025 review in Biomolecules describes counter-ions as binding electrostatically to charged residues and reports that their selection can affect peptide solubility, conformational stability and activity, and that ion-pairing reagents used in chromatography can compromise mass spectrometry compatibility. [2] For a buyer, that means two lots labeled with the same peptide name but different counter-ions are not interchangeable without checking.

Salt form also affects mass-based comparisons. The site's purity-versus-content guide explains why a vial's gross weight includes non-peptide material; the counter-ion is part of that difference.

Regulators list salt forms separately

FDA states that salt forms such as semaglutide sodium and semaglutide acetate are different active ingredients from those used in the approved drugs. [3] The agenda for FDA's July 2026 Pharmacy Compounding Advisory Committee meeting likewise listed each peptide in free-base and acetate forms, for example "BPC-157 (free base and acetate)." [4] Write the salt form whenever you record a regulatory status, or the record may describe a different substance.

Fields to add to your comparison

Add a salt-form column next to purity and content in your supplier comparison. Leave it blank when the supplier does not state it, and ask.

A fictional pair of quotes

Invented quote A offers "Peptide Z, 98% HPLC, TFA salt." Invented quote B offers "Peptide Z, 98% HPLC" with no salt stated. The record should not treat them as equivalent. Note A as TFA salt with no counter-ion content, B as salt form unknown, and send both suppliers the same questions about counter-ion identity, content and method before comparing prices.